PillRx only · Tablet, Extended Release · Oral
Hydromorphone Hydrochloride
Hydromorphone Hydrochloride
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$9.311
Latest avg · Jul 22, 2026
-3%
Since Feb 19, 2025
4
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
590
Rx · 2026 Q1
21K
Units dispensed
+8%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| XLCare Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Padagis US LLC | unknown | 4 | SUPPLYING |
| Trigen Laboratories, LLC | unknown | 4 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.